Evidence map›Paper›PMID 39571693›Full record

ReviewHuman pathology2025

Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: Diagnostic overlaps and defining features.

Ashley K Volaric, Yuri Fedoriw

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Human pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ashley K VolaricDepartment of Pathology and Laboratory Medicine, University of Vermont Larner College of Medicine, 89 Beaumont Avenue, Burlington, VT, 05405, USA.
Yuri FedoriwDepartment of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Lineberger Comprehensive Cancer Center, 160 Medical Drive, Brinkhouse-Bullitt Building, CB#7525, Chapel Hill, NC, 27599, USA. Electronic address: yuri.fedoriw@unchealth.unc.edu.

Funding

The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.U54CA254564 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DITTMER, DIRK P · 2020 to 2024
$6.1M
NCI NIH HHS U54 CA254564
6 · The paper itself

Abstract

This review explores four Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders (LPD) and lymphomas with significant diagnostic overlap: EBV(+) mucocutaneous ulcer (EBVMCU), EBV(+) polymorphic LPD, EBV(+) classic Hodgkin lymphoma (CHL), and EBV(+) diffuse large B-cell lymphoma (DLBCL). Each entity is compared for both overlapping and defining features of clinical presentation, morphology, immunohistochemical profile and EBV expression pattern and latency. Our aims for this review are to provide useful guidance to the practicing pathologist in the diagnosis of these EBV-associated entities.

Indexed as

B-LymphocytesEpstein-Barr Virus InfectionsHodgkin DiseaseLymphoma, Large B-Cell, DiffuseDiagnosis, DifferentialHumansImmunohistochemistryLymphoproliferative DisordersMouth MucosaSkin UlcerB-Cell lymphomaB-Cell lymphoproliferative disorderClassic Hodgkin lymphomaDiffuse large B-Cell lymphomaEBVEpstein-Barr virusImmunodeficiencyMucocutaneous ulcerPolymorphic B-Cell lymphoproliferative disorderPost-transplant

Identifiers

PMID39571693
PMCPMC11890961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.